Clinical Trial Update: Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) [Phase 3]

View source ↗

Summary

Phase 3 trial for an hepatitis B virus antibody booster program intended for production of Hepatitis B immune globulin (HBIG) was terminated; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Emergent BioSolutions | Conditions: Healthy Volunteers | Phase 3 | Status: TERMINATED | Results posted: 2021-08-17